| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Department of Microbiology, University of Heidelberg, Germany;
Research Center Borstel, Borstel, Germany;
Institute for Immunology, University of Heidelberg, Germany;
Department of Internal Medicine, Division of Clinical Pharmacology, University of Munich, Germany;
¶ Max-von-Pettenkofer Institute of Microbiology, University of Munich, Germany;
|| Department of Internal Medicine, Division of Clinical Pharmacology, University of Bonn, Germany
B cells possess functional characteristics of innate immune cells, as they can present Ag to T cells and can be stimulated with microbial molecules such as TLR ligands. Because crude preparations of Staphylococcus aureus are frequently used as polyclonal B cell activators and contain potent TLR2 activity, the scope of this study was to analyze the impact of S. aureus-derived TLR2-active substances on human B cell activation. Peripheral B cells stimulated with chemically modified S. aureus cell wall preparations proliferated in response to stimulation with crude cell wall preparations but failed to be activated with pure peptidoglycan, indicating that cell wall molecules other than peptidoglycan are responsible for B cell proliferation. Subsequent analysis revealed that surface protein A (SpA), similar to BCR cross-linking with anti-human Ig, sensitizes B cells for the recognition of cell wall-associated TLR2-active lipopeptides (LP). In marked contrast to TLR7- and TLR9-triggered B cell stimulation, stimulation with TLR2-active LP and SpA or with crude cell wall preparations failed to induce IgM secretion, thereby revealing qualitative differences in TLR2 signaling compared with TLR7/9 signaling. Notably, combined stimulation with SpA plus TLR2 ligands induced vigorous proliferation of a defined B cell subset that expressed intracellular IgM in the presence of IL-2. Conclusion: S. aureus triggers B cell activation via SpA-induced sensitization of B cells for TLR2-active LP. Combined SpA and TLR2-mediated B cell activation promotes B cell proliferation but fails to induce polyclonal IgM secretion as seen after TLR7 and TLR9 ligation.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 This study was supported by the Deutsche Forschungsgemeinschaft Grant DI898/1-1 (to I.B.-D.), the Deutsche Forschungsgomeinschaft Sonderforschungsbereich Grant 576-B11 (to A.S.), and the Deutsche Forschungsgomeinschaft Priority Program "Innate Immunity" Grant SPP 1110 (to S.I. and U.Z.). G.H. is supported by the Bundesministerium für Bildung und Forschung Biofuture 0311896, Deutsche Forschungsgomeinschaft Grants HA 2780/5-1 and Sonderforschungsbereich 571, and the Mildred-Scheel-Stiftung (Deutsche Krebshilfe) Joint Grant 10-2074-Wo 2.
2 Address correspondence and reprint requests to Dr. Isabelle Bekeredjian-Ding, Department of Microbiology, University of Heidelberg, Im Neuenheimer Feld 324, Heidelberg, Germany. E-mail address: isabelle.bekeredjian-ding{at}med.uni-heidelberg.de
3 Abbreviations used in this paper: SpA, surface protein A; BHK, baby hamster kidney; LP, lipopeptide; LTA, lipoteichoic acid; MALP-2, macrophage-activating lipopeptide-2; Nod, nucleotide oligomerization domain; ODN, oligodeoxynucleotide; OG, N-octyl-
-D-glucopyranoside; SAC, S. aureus Cowan I strain; TA, teichoic acid; WTA, wall teichoic acid; HF, hydrofluoridic acid.
This article has been cited by other articles:
|
|
 |
|
  A. M. Noronha, Y. Liang, J. T. Hetzel, H. Hasturk, A. Kantarci, A. Stucchi, Y. Zhang, B. S. Nikolajczyk, F. A. Farraye, and L. M. Ganley-Leal Hyperactivated B cells in human inflammatory bowel disease J. Leukoc. Biol., October 1, 2009; 86(4): 1007 - 1016. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Jendholm, M. Morgelin, M. L. A. Perez Vidakovics, M. Carlsson, H. Leffler, L.-O. Cardell, and K. Riesbeck Superantigen- and TLR-Dependent Activation of Tonsillar B Cells after Receptor-Mediated Endocytosis J. Immunol., April 15, 2009; 182(8): 4713 - 4720. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Douagi, C. Gujer, C. Sundling, W. C. Adams, A. Smed-Sorensen, R. A. Seder, G. B. Karlsson Hedestam, and K. Lore Human B Cell Responses to TLR Ligands Are Differentially Modulated by Myeloid and Plasmacytoid Dendritic Cells J. Immunol., February 15, 2009; 182(4): 1991 - 2001. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Bekeredjian-Ding, A. Doster, M. Schiller, P. Heyder, H.-M. Lorenz, B. Schraven, U. Bommhardt, and K. Heeg TLR9-Activating DNA Up-Regulates ZAP70 via Sustained PKB Induction in IgM+ B Cells J. Immunol., December 15, 2008; 181(12): 8267 - 8277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Parcina, C. Wendt, F. Goetz, R. Zawatzky, U. Zahringer, K. Heeg, and I. Bekeredjian-Ding Staphylococcus aureus-Induced Plasmacytoid Dendritic Cell Activation Is Based on an IgG-Mediated Memory Response J. Immunol., September 15, 2008; 181(6): 3823 - 3833. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Chiron, I. Bekeredjian-Ding, C. Pellat-Deceunynck, R. Bataille, and G. Jego Toll-like receptors: lessons to learn from normal and malignant human B cells Blood, September 15, 2008; 112(6): 2205 - 2213. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Jendholm, M. Samuelsson, L.-O. Cardell, A. Forsgren, and K. Riesbeck Moraxella catarrhalis-dependent tonsillar B cell activation does not lead to apoptosis but to vigorous proliferation resulting in nonspecific IgM production J. Leukoc. Biol., June 1, 2008; 83(6): 1370 - 1378. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. V. Rubtsov, C. L. Swanson, S. Troy, P. Strauch, R. Pelanda, and R. M. Torres TLR Agonists Promote Marginal Zone B Cell Activation and Facilitate T-Dependent IgM Responses J. Immunol., March 15, 2008; 180(6): 3882 - 3888. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
